Showing 1991-2000 of 2659 results for "".
- SightGlass Vision Receives FDA Breakthrough Device Designation for Myopia Spectacle Lenshttps://modernod.com/news/sightglass-vision-receives-fda-breakthrough-device-designation/2482118/The FDA has granted Breakthrough Device designation to SightGlass Vision's Diffusion Optics Technology (DOT) spectacle lenses, which are intended to slow myopia progression in children. The design is the first to use the contrast management mechanism of action, incorporating thousan
- Sylentis Fails Phase 3 Trial of RNAi-based Drug Candidate for Dry Eye Associated with Sjögren's Syndromehttps://modernod.com/news/sylentis-fails-phase-3-trial-of-rnai-based-drug-candidate-for-dry-eye-associated-with-sjogrens-syndrome/2482110/Sylentis, a subsidiary of Spain-based PharmaMar, announced that its phase 3 SYL10111_V (RNAi-based tivanisiran) clinical trial for the treatment of dry eye disease associated with Sjögren’s syndrome did not meet its primary endpoint—the signs and symptoms of DED. T
- Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in Japanhttps://modernod.com/news/nicox-and-kowa-enter-into-agreement-for-ncx-470-development-and-commercialization-in-japan/2482106/Nicox SA announced the signature of an agreement granting Kowa exclusive Japanese rights to develop and commercialize NCX 470, Nicox’s nitric oxide (NO)-donating bimatoprost eye drop for the lowering of IOP in patients with glaucoma or ocular hypertension. Under the
- Iridex Receives European Patent on MicroPulse Technologyhttps://modernod.com/news/iridex-receives-european-patent-on-micropulse-technology/2482102/Iridex announced the grant of the European Patent 'EP 3009093,' titled "Laser System with Short Pulse Characteristics and its Methods of Use.” This patent protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields for '
- FDA Warns Consumers of Contaminated Copycat Versions of Lumify Eye Dropshttps://modernod.com/news/fda-warns-consumers-of-contaminated-copycat-versions-of-lumify-eye-drops/2482094/FDA is warning consumers not to purchase or use South Moon, Rebright, or FivFivGo eye drops because of the potential risk of eye infection. These are copycat eye drops that consumers can easily mistake for Bausch + Lomb’s Lumify brand eye drops, an over-the-counter product approved for
- Ascendis Pharma Forms New Ophthalmology Company Eyconishttps://modernod.com/news/ascendis-pharma-forms-new-ophthalmology-company-eyconis/2482086/Ascendis Pharma A/S announced the formation and launch of Eyconis, a company created to develop, manufacture, and commercialize TransCon ophthalmology assets globally. The new company was developed with Frazier Life Sciences, as well as an investor syndicate that includes RA Capital Man
- Ocular Therapeutix Announces FDA Agreement to Amend SPA for Clinical Trial of Axpaxli in Wet AMDhttps://modernod.com/news/ocular-therapeutix-announces-fda-agreement-to-amend-spa-for-clinical-trial-of-axpaxli-in-wet-amd/2482079/Ocular Therapeutix announced that the FDA has agreed to a special protocol assessment (SPA) agreement modification for the company’s pivotal phase 3 SOL clinical trial of Axpaxli (axitinib intravitreal implant, also known as OTX-TKI) for the treatment of wet age-related
- Mega-Analysis Identifies Gene Variants Associated with Glaucoma in People of African Ancestryhttps://modernod.com/news/mega-analysis-identifies-gene-variants-associated-with-glaucoma-in-people-of-african-ancestry/2482072/A new analysis focusing specifically on people of African ancestry identified three gene variants that may be contributing to this population’s susceptibility to developing and being blinded by glaucoma, according to report from the Perelman School of Medicine at the University of Pennsylva
- Nidek and Orbis International Partner to Scale Up Artificial Intelligence Eye Screenings in Vietnamhttps://modernod.com/news/nidek-and-orbis-international-partner-to-scale-up-artificial-intelligence-eye-screenings-in-vietnam/2482060/Nidek announced a donation to Orbis International to support Orbis’s artificial intelligence-based screening services in Vietnam. The donation of six specialized fundus cameras, which take images of the retina, will support the scale up of Orbis’ AI-based diabetic retinopathy scr
- Iridex 532 and Iridex 577 Lasers Launched in United Stateshttps://modernod.com/news/iridex-532-and-iridex-577-lasers-launched-in-united-states/2482054/Iridex announced the United States launch of its next-generation platform Iridex 532 and Iridex 577 lasers. According to the company, both lasers harness multiple treatment modes including continuous-wave and the company’s MicroPulse technology and an intuitive touchscreen interfa